We spoke to Dr. Marisa Spann about her work in early childhood psychiatry, her new role in the Office of Equity, Diversity and Inclusion, and having honest, direct conversations about race.
Adrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.
This study “adds to a growing literature of using electrophysiological outcomes, including mismatch negativity as predictive biomarkers,” commented Dr. Joshua Kantrowitz.
Structural differences in the cerebellum may be linked to some aspects of autism spectrum disorder, according to a neuroimaging study from Columbia University Irving Medical Center (CUIMC).
Researchers at Columbia University Irving Medical Center (CUIMC) identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
Long assumed to be a mere "relay," an often-overlooked structure in the middle of the brain also turns out to play a pivotal role in tuning-up thinking circuity.
Dr. Eric Kandel, applauded the museum’s effort... “I think this is the future,” said Kandel, who’s written extensively on the relationship between neuroscience and the visual arts.
“Ketamine, as a treatment, is often paired with the experience or during consolidation of memories or some type of arousal related to the experience,” said Dr. Christine Denny.